Managing high-risk stroke patients using social networks
COmprehensive Management of High-risk PopuLatIon of Stroke bAsed oN soCial nEtwork: a Multicenter, Parallel and Randomized Controlled sTudy
This study tests if using WeChat Mini Programs can help high-risk stroke patients remember to take their medications and manage their health better after leaving the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 720 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai) |
| Trial ID | NCT05963828 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of using social networks, specifically WeChat Mini Programs, to improve medication compliance and control risk factors in high-risk stroke patients after hospital discharge. It is a multicenter, prospective, randomized, single-blind study that follows patients for 12 months to assess changes in their medication adherence. The goal is to enhance comprehensive management of stroke patients, thereby reducing recurrence rates and improving overall health outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are hospitalized for stroke and have a modified Rankin Scale score of 2 or less.
Not a fit: Patients who cannot operate smartphones or have other serious health conditions that interfere with follow-up assessments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve medication adherence and reduce the risk of stroke recurrence in high-risk patients.
How similar studies have performed: Other studies have shown promise in using technology for patient management, but this specific approach utilizing social networks is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * High-risk population of stroke for hospitalization * Modified Rankin Scale score≤ 2 * Patients or primary caregiver have smart phone and wechat accounts * Patients take at least one drug for a long time (antihypertensive, hypoglycemic, lipid-lowering, anticoagulant, antiplatelet drugs) * Written informed consent Exclusion Criteria: * Patients and their families are unable to operate smartphones * Having other diseases that interfere with clinical follow-up assessment (such as cancer, dementia, severe mental illness, etc.) * Life expectancy is less than 12 months * Patients living in the absence of network conditions
Where this trial is running
Shanghai, Shanghai
- Changhai Hospital — Shanghai, Shanghai, China (Recruiting)
Study contacts
- Study coordinator: Qiao mengting
- Email: pour7788@163.com
- Phone: 15039464902
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.